Shingles Vaccine Study

Shingles is a painful rash that develops from a viral infection. Shingles can occur at any age, however the risk of developing shingles increases with age. Around 1 in 3 people will develop shingles during their lifetime. Shingles can cause complications, particularly in older adults. These include, predominantly, long-term pain, as well as other, more infrequent but serious complications such as vision loss, hearing loss, and inflammation of the brain. Vaccination is the best protection against shingles.

‍

That’s why we’re looking for people aged 70 years old and older and in good health to take part in the Shingles Vaccine Study. This study is testing a new investigational shingles vaccine that is being developed to have fewer side effects than the current licensed shingles vaccine.

‍

By taking part in this study, you may help improve health outcomes in Australia and globally.

‍

There are no overnight stays required for this study.